文献速递淋巴瘤造血干细胞移植与细胞治疗

套细胞淋巴瘤自体造血干细胞移植后复发时间对总生存的影响

Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.
PubMed 文献 · Br J Haematol · 2021-09-28

该回顾性研究利用CIBMTR数据库,纳入461例诊断后12个月内接受autoHCT的套细胞淋巴瘤患者,评估移植后复发时间对总生存的影响。多因素分析显示复发对OS的影响在6、12、18个月里程碑点最大,早期复发(<18个月)定义高危组,强调需考虑新疗法。

要点

  • 动态里程碑模型显示各时点后5年调整OS随时间改善,复发与未复发患者均如此。
  • autoHCT后早期复发(<18个月)为高危组,复发后OS较差。

核心结论

  • autoHCT后复发时间影响MCL患者OS,早期复发(<18个月)定义高危组且复发后OS较差。

研究设计与样本

  • 回顾性分析利用CIBMTR数据库,纳入461例诊断后12个月内接受autoHCT的MCL患者。

主要发现

  • 动态里程碑模型显示各里程碑点后5年调整OS随时间改善,复发与未复发患者均如此。
  • 早期复发(<18个月)后OS较差。

临床怎么用

  • 对autoHCT后早期复发(<18个月)的MCL患者应考虑新型治疗方法。

局限性

  • 为回顾性分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In young and fit patients with mantle cell lymphoma (MCL), intensive induction therapy followed by a consolidative autologous haematopoietic cell transplant (autoHCT) is the standard of care in the front-line setting. Recently, time-to-event analysis has emerged as an important risk assessment tool in lymphoma, though its impact in MCL is not well defined. We utilized the Center for International Blood and Marrow Transplant Research database to evaluate the effect of post-autoHCT time to relapse on overall survival (OS) over time in 461 patients who underwent autoHCT within 12 months of MCL diagnosis. On multivariate analysis, the impact of relapse on OS was greatest at the six-month [hazard ratio (HR) = 7·68], 12-month (HR = 6·68), and 18-month (HR = 5·81) landmark timepoints. Using a dynamic landmark model we demonstrate that adjusted OS at five years following each landmark timepoint improved with time for relapsing and non-relapsing patients. Furthermore, early relapse (<18 months) following autoHCT defines a high-risk group with inferior post-relapse OS. This retrospective analysis highlights the impact of time to relapse on OS in MCL patients undergoing up-front autoHCT and emphasizes the need to consider novel therapeutic approaches for patients suffering early relapse.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Riedell PA, Hamadani M, Ahn KW, et al. Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation. Br J Haematol. 2021. PMID: 34581433. doi:10.1111/bjh.17865

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。